GHK-Cu has more extensive human clinical research, particularly in dermatological applications
Tirzepatide 5 mg demonstrated weight loss superiority relative to placebo (MD: 12.47 kg, 95% CI: 13.94 kg to 11.00 kg) and semaglutide ( n = 1409, MD: 1.90 kg, 95% CI: 2.97 kg to 0.83 kg) with dose-dependent increase for 10 mg and 15 mg doses
A dose-dependent response was also observed in their study [25]
Over-the-Counter and Medical Interventions for Nausea Relief Ginger supplements (5001,000 mg daily), vitamin B6 (2550 mg daily), and acupressure wristbands targeting the P6 meridian point have shown modest effectiveness in clinical studies for general nausea management
Lauti M, Kularatna M, Hill AG, et al